We are live on ! Find out more
CIC

Cornercap Investment Counsel Portfolio holdings

AUM $203M
1-Year Est. Return 17.67%
This Fund
S&P 500
This Quarter Est. Return
+10.87%
1 Year Est. Return
+17.67%
3 Year Est. Return
+55.44%
5 Year Est. Return
+79.88%
10 Year Est. Return
+193.02%
AUM
$578M
AUM Growth
+$47.7M
Cap. Flow
+$2.02M
Cap. Flow %
0.35%
Top 10 Hldgs %
8.73%
Holding
665
New
115
Increased
180
Reduced
145
Closed
106

Top Buys

Rank Stock Value
1
PYPL icon
PayPal
PYPL
+$2.1M
2
ELV icon
Elevance Health
ELV
+$2.08M
3
FOXA icon
Fox Class A
FOXA
+$1.97M
4
TMUS icon
T-Mobile US
TMUS
+$1.96M
5
WM icon
Waste Management
WM
+$1.87M

Top Sells

Rank Stock Value
1
ORCL icon
Oracle
ORCL
+$4.29M
2
SYF icon
Synchrony
SYF
+$3.13M
3
SSNC icon
SS&C Technologies
SSNC
+$2.87M
4
AEP icon
American Electric Power
AEP
+$2.59M
5
MU icon
Micron Technology
MU
+$2.21M

Sector Composition

Rank Sector Weight
1 Financials 20.35%
2 Healthcare 13.96%
3 Technology 13.54%
4 Industrials 12.88%
5 Energy 9.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NGM
501
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$231K 0.04%
46,062
+34,563
+301% +$217K
TTEK icon
502
Tetra Tech
TTEK
$8.97B
$230K 0.04%
7,935
ANNX icon
503
Annexon
ANNX
$883M
$230K 0.04%
44,515
NUVB icon
504
Nuvation Bio
NUVB
$2.32B
$229K 0.04%
119,285
+43,356
+57% +$87.7K
APD icon
505
Air Products & Chemicals
APD
$68.6B
$228K 0.04%
+740
New +$209K
QVCGA
506
DELISTED
QVC Group Inc Series A
QVCGA
$228K 0.04%
2,795
-58
-2% -$5.91K
HOLX
507
DELISTED
Hologic
HOLX
$228K 0.04%
3,042
-550
-15% -$39.2K
APH icon
508
Amphenol
APH
$207B
$226K 0.04%
+5,940
New +$225K
COO icon
509
Cooper Companies
COO
$14.9B
$222K 0.04%
+2,688
New +$198K
LENZ
510
LENZ Therapeutics
LENZ
$168M
$221K 0.04%
9,490
GLUE icon
511
Monte Rosa Therapeutics
GLUE
$1.35B
$215K 0.04%
28,192
SGMO
512
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$213K 0.04%
67,910
+17,545
+35% +$68.1K
DINO icon
513
HF Sinclair
DINO
$15.2B
$210K 0.04%
4,042
-90
-2% -$5.18K
ALEC icon
514
Alector
ALEC
$189M
$209K 0.04%
22,678
+1,811
+9% +$15.8K
NRIX icon
515
Nurix Therapeutics
NRIX
$2.69B
$206K 0.04%
+18,756
New +$226K
EVR icon
516
Evercore
EVR
$11.5B
$205K 0.04%
1,882
-8,007
-81% -$836K
KLRS
517
Kalaris Therapeutics
KLRS
$93.7M
$203K 0.04%
1,717
-239
-12% -$40.5K
IMGN
518
DELISTED
Immunogen Inc
IMGN
$179K 0.03%
36,067
+234
+0.7% +$1.27K
MGTX icon
519
MeiraGTx Holdings
MGTX
$1.21B
$176K 0.03%
26,947
+239
+0.9% +$1.64K
PRAX icon
520
Praxis Precision Medicines
PRAX
$10.2B
$174K 0.03%
4,865
+15
+0.3% +$468
CGEM icon
521
Cullinan Oncology
CGEM
$1.18B
$168K 0.03%
15,939
FHTX icon
522
Foghorn Therapeutics
FHTX
$371M
$167K 0.03%
+26,163
New +$197K
DTIL icon
523
Precision BioSciences
DTIL
$206M
$160K 0.03%
4,476
+43
+1% +$1.7K
CCCC icon
524
C4 Therapeutics
CCCC
$400M
$155K 0.03%
26,291
+4,690
+22% +$38.9K
NKTR icon
525
Nektar Therapeutics
NKTR
$2.53B
$146K 0.03%
4,293

Similar funds

Cornercap Investment Counsel's Q4 2022 Portfolio in Review

As of Q4 2022, Cornercap Investment Counsel held 665 positions worth $578M, up 9% from $530M the previous quarter. Its ten largest holdings account for 8.7% of the portfolio.

Cornercap Investment Counsel's Q4 2022 filing shows 115 new, 180 increased, 145 reduced and 106 closed positions. Its largest new stake was PayPal: 26,281 shares worth $1.87M. The largest sale was Oracle, an estimated $4.29M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Technology.

  • Cornercap Investment Counsel's largest Q4 2022 buy was PayPal: 26,281 shares worth $1.87M.
  • Cornercap Investment Counsel added most to ExxonMobil in Q4 2022, an estimated $1.36M increase.
  • Cornercap Investment Counsel's biggest Q4 2022 reduction was Oracle, cutting an estimated $4.29M.
  • Cornercap Investment Counsel fully exited American Electric Power in Q4 2022, selling an estimated $2.59M.
  • Cornercap Investment Counsel's ten largest holdings make up 8.7% of its $578M portfolio in Q4 2022.
  • Cornercap Investment Counsel opened 115 new positions and closed 106 in Q4 2022.
  • Cornercap Investment Counsel's portfolio value rose 9% quarter-over-quarter to $578M.

Based on Cornercap Investment Counsel's 13F filing for Q4 2022, filed 13 Feb 2023.